1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The National Cardiovascular Health Program is sponsored by Department of Health And Human Services (HHS). This program supports extensive scientific evidence, links nonmedical factors, including systemic racism and the lack of economic opportunities, with poor health outcomes and increased mortality rates, all of which are preventable.
It aims to implement and evaluate evidence-based strategies to prevent and manage cardiovascular disease (CVD) in populations disproportionately at risk.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Health And Human Services (HHS)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: State Governments or their Bona Fide Agents (includes the District of Columbia). Confirm the full requirements in the official notice before applying.
The current listing shows recent federal obligations suggest $75,993,412 (2026). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The National Cardiovascular Health Program is funded by Department of Health And Human Services (HHS). Verify program details on the funder's official page before applying.
This opportunity targets applicants in District of Columbia. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The HHS Grants Policy Statement that took effect October 1, 2025 raised the micro-purchase threshold to $50,000, the single audit threshold to $1 million, and the de minimis indirect cost rate to 15 percent — quietly rewriting the operational rules for tens of billions of dollars in annual awards. Combined with full 2 CFR Parts 200 and 300 adoption and new MAHA-aligned program priorities, it is the biggest compliance shift for health grantees since Uniform Guidance arrived in 2013.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleHHS launched the STREETS Initiative and SAMHSA announced $69M in mental health grants as part of the Great American Recovery. A deep analysis of eligibility, strategy, and what organizations should apply.
Read article